Marija Balic

Section chief for Medical Breast Oncology

University of Pittsburgh Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marija Balic is the Section Chief for Medical Breast Oncology at the University of Pittsburgh Medical Center in the United States. Her research focuses on breast cancer, including quality of life in clinical trials, the impact of neoadjuvant therapies, and molecular subtypes in breast cancer populations. Recent publications highlight her work on tumor microenvironments and long-term outcomes in different breast cancer histologies.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Richard Buus

Institute of Cancer Research

UNITED KINGDOM

View details

Edgar Petru

Medical University of Graz

AUSTRIA

View details

Stewart Anderson

Professor

University of Pittsburgh

UNITED STATES

View details

Justin M. Balko

Vanderbilt University Medical Center

UNITED STATES

View details

Charles Edward Geyer Jr

Professor of Medicine in Division of Hematology/Medical Oncology

University of Pittsburgh

UNITED STATES

View details

Adrian V. Lee

University of Pittsburgh

UNITED STATES

View details

Eileen Shinn

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jun Mao

Chief of Integrative Medicine

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Peter Regitnig

Medical University of Graz

AUSTRIA

View details

Michael Gnant

Full Professor

Medical University of Vienna

AUSTRIA

View details

Miguel Martin

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marija Balic

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)

Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials

Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression

Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

Deciphering the molecular landscape of metastatic lobular breast cancer

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the ABCSG Trial 5

Collaborators (11)

Richard Buus

Edgar Petru

Stewart Anderson

Justin M. Balko

Charles Edward Geyer Jr

Adrian V. Lee

Eileen Shinn

Jun Mao

Peter Regitnig

Michael Gnant

Miguel Martin

Make your next move.